tazarotene has been researched along with Ichthyosis in 5 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Ichthyosis: Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with recessive ichthyosis for whom daily application of topical tazarotene produced rapid and persistent improvement of bilateral lower eyelid ectropion without adverse effects." | 7.79 | Topical tazarotene for the treatment of ectropion in ichthyosis. ( Choate, KA; Craiglow, BG; Milstone, LM, 2013) |
| "We describe a patient with recessive ichthyosis for whom daily application of topical tazarotene produced rapid and persistent improvement of bilateral lower eyelid ectropion without adverse effects." | 3.79 | Topical tazarotene for the treatment of ectropion in ichthyosis. ( Choate, KA; Craiglow, BG; Milstone, LM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craiglow, BG | 1 |
| Choate, KA | 1 |
| Milstone, LM | 1 |
| Marulli, GC | 1 |
| Campione, E | 1 |
| Chimenti, MS | 1 |
| Terrinoni, A | 1 |
| Melino, G | 1 |
| Bianchi, L | 1 |
| Henno, A | 1 |
| Hua, MT | 1 |
| de la Brassinne, M | 1 |
| Barbarot, S | 1 |
| Acher-Chenebaux, A | 1 |
| Stalder, JF | 1 |
| Nguyen, V | 1 |
| Cunningham, BB | 1 |
| Eichenfield, LF | 1 |
| Alió, AB | 1 |
| Buka, RL | 1 |
1 review available for tazarotene and Ichthyosis
| Article | Year |
|---|---|
[Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
Topics: Administration, Topical; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Ichthyosis; | 2003 |
1 trial available for tazarotene and Ichthyosis
| Article | Year |
|---|---|
[Topical tazarotene for severe congenital ichthyosis].
Topics: Administration, Topical; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Ichthyosis; Inf | 2006 |
3 other studies available for tazarotene and Ichthyosis
| Article | Year |
|---|---|
Topical tazarotene for the treatment of ectropion in ichthyosis.
Topics: Administration, Cutaneous; Aged; Ectropion; Female; Humans; Ichthyosis; Keratolytic Agents; Nicotini | 2013 |
Type I lamellar ichthyosis improved by tazarotene 0.1% gel.
Topics: Administration, Topical; Adult; Dermatologic Agents; Female; Gels; Humans; Ichthyosis; Nicotinic Aci | 2003 |
Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Dermatologic Agents; Female; Humans; I | 2007 |